Importer of Controlled Substances Registration, 52908 [2016-18922]
Download as PDF
<![CDATA[
52908
Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices
replace the volume of articles
potentially subject to the recommended
orders within a commercially
reasonable time; and
(v) explain how the recommended
orders would impact consumers in the
United States.
Written submissions must be filed no
later than by close of business on
September 6, 2016.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to
Commission Rule 210.4(f), 19 CFR
210.4(f). Submissions should refer to the
investigation number (‘‘Inv. No. 947’’) in
a prominent place on the cover page
and/or the first page. (See Handbook for
Electronic Filing Procedures, https://
www.usitc.gov/secretary/fed_reg_
notices/rules/handbook_on_electronic_
filing.pdf). Persons with questions
regarding filing should contact the
Secretary, (202) 205–2000.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All non-confidential
written submissions will be available for
public inspection at the Office of the
Secretary and on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and part 210 of the Commission’s Rules
of Practice and Procedure (19 CFR part
210).
Company
mstockstill on DSK3G9T082PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
17:34 Aug 09, 2016
Jkt 238001
[FR Doc. 2016–18904 Filed 8–9–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUMMARY:
FR Docket
Mylan Pharmaceuticals, Inc. ...................................................
Hospira ....................................................................................
Cambrex Charles City ............................................................
Pharmacore ............................................................................
Mallinckrodt LLC .....................................................................
Meda Pharmaceuticals, Inc. ...................................................
Stepan Company ....................................................................
VerDate Sep<11>2014
By order of the Commission.
Issued: August 4, 2016.
Lisa R. Barton,
Secretary to the Commission.
80
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
Published
75691 ..........................................................................
1208 ............................................................................
14892 ..........................................................................
15565 ..........................................................................
15566 ..........................................................................
15560 ..........................................................................
20417 ..........................................................................
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2016–18922 Filed 8–9–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
PO 00000
Notice of registration.
Frm 00099
Fmt 4703
Sfmt 4703
December 3, 2015.
January 11, 2016.
March 18, 2016.
March 23, 2016.
March 23, 2016.
March 23, 2016.
April 7, 2016
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Page 52908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18922]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as an importer of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Mylan Pharmaceuticals, Inc... 80 FR 75691.... December 3, 2015.
Hospira...................... 81 FR 1208..... January 11, 2016.
Cambrex Charles City......... 81 FR 14892.... March 18, 2016.
Pharmacore................... 81 FR 15565.... March 23, 2016.
Mallinckrodt LLC............. 81 FR 15566.... March 23, 2016.
Meda Pharmaceuticals, Inc.... 81 FR 15560.... March 23, 2016.
Stepan Company............... 81 FR 20417.... April 7, 2016
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18922 Filed 8-9-16; 8:45 am]
BILLING CODE 4410-09-P
